Testing the safety of avelumab and axitinib on patients with kidney cancer (JAVELIN Renal 100)

A Phase 1b, Open-Label, Dose-Finding Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB0010718C) in Combination With Axitinib (AG-013736) in Patients With Previously Untreated Advanced Renal Cell Cancer

Category & Conditions:
Cancer
Medicine:
Bavencio (avelumab)
INLYTA®(AXITINIB)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B9991002
Open Plain Language Summary Result:Click here